Tekla Capital Management LLC Ascendis Pharma A/S Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Tekla Capital Management LLC holds 138,791 shares of ASND stock, worth $18.8 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

138,791

Previous 123,791 12.12%

Holding current value

$18.8 Million

Previous $13.3 Million 6.67%

% of portfolio

0.49%

Previous 0.51%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$69.96 - $97.84 $1.05 Million - $1.47 Million	15,000 Added 12.12%	138,791 $12.4 Million
Q4 2022 Feb 10, 2023	BUY	$99.42 - $131.97 $5.57 Million - $7.39 Million	55,997 Added 82.6%	123,791 $15.1 Million
Q3 2021 Nov 12, 2021	SELL	$112.67 - $176.92 $9.67 Million - $15.2 Million	-85,842 Reduced 55.87%	67,794 $10.8 Million
Q2 2021 Aug 13, 2021	BUY	$121.62 - $145.29 $4.29 Million - $5.13 Million	35,300 Added 29.83%	153,636 $20.2 Million
Q1 2021 May 14, 2021	BUY	$124.92 - $173.33 $2.76 Million - $3.83 Million	22,090 Added 22.95%	118,336 $15.3 Million

Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $4.46 Million - $5.39 Million	-29,500 Reduced 23.46%	96,246 $16.1 Million
Q3 2020 Nov 13, 2020	BUY	$134.29 - $154.32 $9.17 Million - $10.5 Million	68,264 Added 118.76%	125,746 $19.4 Million
Q2 2020 Aug 13, 2020	SELL	$110.87 - $156.01 $1.31 Million - $1.85 Million	-11,850 Reduced 17.09%	57,482 $8.5 Million
Q4 2019 Feb 13, 2020	SELL	$91.45 - $139.12 $716,510 - $1.09 Million	-7,835 Reduced 10.15%	69,332 $9.65 Million
Q3 2019 Nov 13, 2019	BUY	$95.8 - $118.9 $337,216 - $418,528	3,520 Added 4.78%	77,167 $7.43 Million
Q2 2019 Aug 14, 2019	BUY	$107.11 - $132.09 $1.32 Million - $1.62 Million	12,287 Added 20.02%	73,647 $8.48 Million
Q1 2019 May 14, 2019	BUY	$62.15 - $129.99 $1.18 Million - $2.46 Million	18,961 Added 44.72%	61,360 $7.22 Million
Q4 2018 Feb 13, 2019	SELL	$55.16 - $69.67 $1.29 Million - $1.62 Million	-23,315 Reduced 35.48%	42,399 $2.66 Million
Q3 2018 Nov 13, 2018	BUY	$63.77 - $76.28 $1.39 Million - $1.66 Million	21,800 Added 49.64%	65,714 $4.66 Million
Q2 2018 Aug 13, 2018	BUY	$58.55 - $73.92 $2.21 Million - $2.79 Million	37,700 Added 606.69%	43,914 $2.92 Million
Q1 2018 May 14, 2018	BUY	$38.98 - $68.04 $242,221 - $422,800	6,214 New	6,214 $406,000

Others Institutions Holding ASND

# of Institutions

211

Shares Held

46.5M

Call Options Held

310K

Put Options Held

306K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.56B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Ascendis Pharma A/S Transaction History